Gateway 2012: Meissner Filtration Products - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Meissner Filtration Products


Meissner Filtration Products
4181 Calle Tesoro
Camarillo, CA  93012
Phone: 800.391.9458
Int'l.: +1.805.388.9911

www.meissner.com

Questions? info@meissner.com

Company description
Meissner is your source for advanced microfiltration and single-use systems. Focused on fluid technology innovation, we leverage our R&D efforts to offer our clients products that deliver advanced processing and fluid handling solutions for pharmaceutical and biopharmaceutical manufacturing.

Our One-Touch® single-use product portfolio demonstrates our commitment to manufacture innovative products. We introduced the industry's first slip agent-free PE biocontainers, TepoFlex®, thus reducing its extractables profile, and giving the biocontainer its remarkable visual clarity. We also delivered the industry's only multilayer PVDF biocontainer, FluoroFlex®, thus expanding the application of single-use systems beyond the limits of existing PE biocontainers, and into areas such as API storage.

Booth Invitations/Products Promoted
Meissner invites you to join us at INTERPHEX New York May 1st – 3rd. Meissner will be exhibiting in booth #2817. We will be featuring our One-Touch® single-use systems, including TepoFlex® PE biocontainer assemblies (2D & 3D configurations from 50 mL – 1,000 L), FluoroFlex® PVDF biocontainer assemblies (50 mL – 20 L), BioFlex® tubing assemblies (with optional PVDF or PES membranes filters for sterilizing grade applications, as well as a range of additional media for applications from clarification through sterilization) and FlexStation® rigid outer containers that complement TepoFlex® 3D biocontainers (from 100 L – 1,000 L). We will also feature the newly available QuaDrum™ containers (from 50 L – 200 L), FlexFill™ biocontainer transfer assemblies, and a host of FlexCessories™ to complement and support the One-Touch® portfolio (e.g. End-ported biocontainer hanging stand, ergonomic biocontainer hangers).

Meissner will also be exhibiting at the BIO International Convention, Boston, in booth #480, at ACHEMA, Frankfurt, Germany, in Hall 5, Stand E5, and at the BioProcess International Conference & Exhibition, Rhode Island, in booth #703.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here